Recent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize animal testing over innovative human-based methods, despite ...

Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of the cobas® eplex respiratory pathogen panel 3 (RP3). Designed for the automated cobas® eplex system, this flexible ...

A view of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association [Financial News] The Korea Pharmaceutical and Bio ...

Weill Cornell researchers developed an experimental compound targeting a weakness in cancer cells that have lost an enzyme ...

Carr’s saliva sample returned negative after a roadside drug test in Australia. Police expect no further action, while Parramatta Eels are yet to decide his future.

A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to ...

A landmark multi-institution collaboration has found no reproducible lasting behavioural changes in mice 24 hours after a ...

Labcorp Holdings (NYSE: LH) partnered with Waters Corporation to deploy the BD Onclarity HPV Assay across its national ...

Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat ...

Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.

The change “reflects the collective impact of ongoing efforts,” an expert from the National Safety Council said.

Anthropic is moving deeper into drug development, and its most striking example is not a claim that Claude discovered a cure.